Dupilumab in eosinophilic cellulitis (Wells' syndrome) - case report of a potential new treatment option

J Dtsch Dermatol Ges. 2021 Nov;19(11):1653-1655. doi: 10.1111/ddg.14598. Epub 2021 Sep 22.

Authors

Stephan Traidl¹, Yenny Angela¹, Alexander Kapp¹, Hendrik Suhling², Vivien Schacht¹, Thomas Werfel¹

Affiliations

¹ Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany.
² Department of Pneumology, Hannover Medical School, Member of the German Center for Lung Research (DZL), Hannover, Germany.

PMID: 34549522
DOI: 10.1111/ddg.14598

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal, Humanized
Cellulitis* / diagnosis
Cellulitis* / drug therapy
Eosinophilia* / diagnosis
Eosinophilia* / drug therapy
Humans

Substances

Antibodies, Monoclonal, Humanized
dupilumab

Supplementary concepts

Wells syndrome